News Category
Resilient Performance Group has identified a commercial exposure it calls the Landing Gap, the unpriced risk that arises when a drug asset developed u...
BioVersys and GSK will present Phase 2 data on alpibectir-ethionamide for drug-sensitive pulmonary tuberculosis at The Union World Conference on Lung ...
Quantum BioPharma's private placement of Class A multiple voting shares to CEO- and director-affiliated entities raised insider aggregate voting power...
Onco-Innovations has agreed to terminate its performance-based funding arrangement with Sorbie, resulting in the cancellation of 5.38 million shares a...
Quantum BioPharma's private placement of multiple voting shares increases insider voting control to 68.22%, raising governance and dilution concerns a...
Creative Biolabs is promoting three complementary RNA profiling and visualization approaches to help researchers address blind spots in single-cell an...
Lantern Pharma's published Phase 1a data for LP-184 in recurrent glioblastoma, though limited by modest brain tumor exposure, provide a dosing rationa...
MIT researchers have engineered donor immune cells that nearly wiped out lymphoma in mice within three weeks without being rejected, potentially overc...
NanoViricides is advancing its broad-spectrum antiviral drug NV-387 into Phase II clinical trials for measles, addressing an unmet medical need as mea...
Sino Biological's 4RISE™ platform addresses the critical bottleneck in AI-driven protein design by providing integrated wet-lab validation, enabling f...
Tonix Pharmaceuticals reported a sharp jump in third-quarter revenue driven by strong TONMYA sales, while advancing its clinical pipeline and extendin...
Lifordi Immunotherapeutics' Phase 1 data for LFD-200, a subcutaneous glucocorticoid antibody-drug conjugate, demonstrate safety and anti-inflammatory ...
GeoVax Labs will implement a 1-for-24 reverse stock split on November 11, 2026, to raise its share price above the $1.00 minimum bid required for cont...
Quantum BioPharma filed a supplement to its shareholder meeting materials to clarify rounding rules and a 70% voting power cap for its proposed share ...
The 2026 Activated Egg Symposium in Boston will gather leading scientists to explore how human eggs activate and begin development, with implications ...
A German Federal Patent Court ruling upholding the cancellation of CeramTec's pink trademark for ceramic hip components strengthens CoorsTek Biocerami...
Annovis Bio's $21 million public offering will fund continued clinical development of buntanetap for Alzheimer's and Parkinson's diseases, a critical ...
Kairos Pharma's ENV-105 receives the 2026 Biotech Breakthrough Award for Cancer Immunology, highlighting its potential to overcome treatment resistanc...
A new study reveals that 20% of patients with dental infections are prescribed a high-risk antibiotic, highlighting the need for better prescribing pr...
Scinai Immunotherapeutics reported 167% revenue growth to $2.8 million for the first nine months of 2026, driven by CDMO expansion, alongside $8.32 mi...
Annovis Bio's proposed public offering aims to raise capital to advance its lead drug candidate buntanetap through Phase 3 trials for Alzheimer's and ...
Viromed Medical AG's early approval of ViroCAP® med in Turkey, backed by binding orders and reimbursement progress, marks a key step in the company's ...
Heidelberg Pharma will present new clinical data on its lead ATAC candidate pamlectabart tismanitin and second candidate HDP-102 at the 68th ASH Annua...
Tonix Pharmaceuticals' upcoming presentation at the Guggenheim Healthcare Innovation Conference provides a platform to highlight its commercial-stage ...
Quantum BioPharma is advancing a diversified strategy that combines clinical drug development, consumer wellness, and royalty-based partnerships to ad...
The October 2026 Wellness Index Report identifies three builders of healthspan, highlighting a shift from hoping for a longer life to engineering one ...
Sequencio Therapeutics will present preclinical data at SITC 2026 showing its TROP2 and PD-L1/PRAME cancer vaccines generate targeted immune responses...
Quantum BioPharma's unbuzzd supplement drink, designed to support alcohol metabolism, has received early praise from Men's Fitness following a small p...
Kairos Pharma's ENV-105 doubled median progression-free survival in metastatic castration-resistant prostate cancer, potentially offering a new way to...
Adaptogenics Health Corp. is building its peptide strategy around supply verification and traceability as U.S. regulators advance an interim access po...
Quantum BioPharma’s unbuzzd supplement, designed to support alcohol metabolism, has drawn scrutiny from Men’s Fitness after a placebo-controlled trial...
ABVC BioPharma's $3.39 million private placement of original issue discount convertible notes provides working capital, funds subsidiaries, and settle...
Tonix Pharmaceuticals appoints George Lederman, son of the CEO, as EVP of strategy and transformation to lead AI initiatives and business development,...
Okogen has dosed the first patient in its Phase 1/2 EMERALD Trial of Treyegen, a single ophthalmic therapy for acute infectious conjunctivitis, markin...
Catherine Cifuentes-Rojas released a free checklist to help biotherapeutics teams make evidence-based go/no-go decisions, aiming to protect capital an...
VERAXA Biotech is expanding its use of human-relevant preclinical testing methods, which could improve the clinical relevance of its cancer drug resea...
Quantum BioPharma's agreement with Thermo Fisher Scientific's clinical research business marks a key step toward launching a Phase 2 trial for Lucid-M...
A preclinical study demonstrates that a dual-targeting antibody can effectively combat multiple tumor types in mice, offering a potential strategy to ...
Helix BioPharma cut its annual net loss to $3.35 million while advancing its L-DOS47 clinical program, but the company disclosed a working capital def...
Regentis Biomaterials is advancing its GelrinC hydrogel implant for cartilage repair, with promising clinical data and regulatory progress that could ...
Annovis Bio's CEO will present at two November industry conferences, offering investors and partners a closer look at the company's Phase 3 clinical p...
Oncotelic Therapeutics is using a validated four-gene liver cancer survival signature, surfaced by its Partitioned Literature Aggregation algorithm, a...
TransCode Therapeutics has initiated a formal strategic review to evaluate options for maximizing value, including potential licensing, partnerships, ...
Enodia Therapeutics has named Henrik Torp Nielsen as Chief Financial Officer, bringing nearly two decades of biopharma finance experience to steer the...
Certified-PEP's 2026 Research Peptide Supplier Comparison evaluates 10 suppliers on testing transparency and documentation, underscoring the importanc...
A Phase 3 trial combining two immunotherapy drugs nearly doubled median survival in patients with a deadly form of lung cancer, signaling a potential ...
VolitionRx's nonbinding LOI with Missionpharma aims to develop and commercialize a low-cost, finger-prick NETosis test for neonatal sepsis, potentiall...
Creative Biolabs highlights functional complement assays and a microfluidic droplet generation chip to help researchers improve data reliability and w...
